Stephen Kim1, Dana Russell2, Mehdi Mohamadnejad1, Jitin Makker1, Alireza Sedarat1, Rabindra R Watson1, Shangxin Yang3, Peera Hemarajata3, Romney Humphries3, Zachary Rubin4, V Raman Muthusamy1. 1. Division of Digestive Diseases, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA. 2. Clinical Epidemiology and Infection Prevention, University of California, Los Angeles Health, Los Angeles, California, USA. 3. Pathology and Laboratory Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA. 4. Infectious Diseases, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA.
Abstract
BACKGROUND AND AIMS: The duodenoscopes used to perform ERCP have been implicated in several outbreaks of carbapenem-resistant Enterobacteriaceae (CRE) infection. The risk factors for CRE transmission via contaminated duodenoscopes remain unclear. METHODS: In this retrospective, single-center, case-control study, all patients who underwent ERCP with either 1 of 2 contaminated duodenoscopes were evaluated. We compared the patients who acquired CRE (active infection or colonization) with those who did not. RESULTS: Between October 3, 2014, and January 28, 2015, a total of 125 procedures were performed on 115 patients by using either of the contaminated duodenoscopes. Culture data were available for 104 of the 115 exposed patients (90.4%). Among these patients, 15 (14.4%) became actively infected (n = 8, 7.7%) or colonized (n = 7, 6.7%) with CRE. On univariate analysis, recent antibiotic exposure (66.7% vs 37.1%; P = .046), active inpatient status (60.0% vs 28.1%; P = .034), and a history of cholangiocarcinoma (26.7% vs 3.4%; P = .008) were patient characteristics associated with an increased risk of CRE infection. Biliary stent placement (53.3% vs 22.5%; P = .024) during ERCP was a significant procedure-related risk factor. After adjusting for cholangiocarcinoma, biliary stent placement (odds ratio 3.62; 95% confidence interval, 1.12-11.67), and active inpatient status (odds ratio 3.74; 95% confidence interval, 1.15-12.12) remained independent risk factors for CRE transmission. CONCLUSIONS: In patients undergoing ERCP with a contaminated duodenoscope, biliary stent placement, a diagnosis of cholangiocarcinoma, and active inpatient status are associated with an increased risk of CRE transmission.
BACKGROUND AND AIMS: The duodenoscopes used to perform ERCP have been implicated in several outbreaks of carbapenem-resistant Enterobacteriaceae (CRE) infection. The risk factors for CRE transmission via contaminated duodenoscopes remain unclear. METHODS: In this retrospective, single-center, case-control study, all patients who underwent ERCP with either 1 of 2 contaminated duodenoscopes were evaluated. We compared the patients who acquired CRE (active infection or colonization) with those who did not. RESULTS: Between October 3, 2014, and January 28, 2015, a total of 125 procedures were performed on 115 patients by using either of the contaminated duodenoscopes. Culture data were available for 104 of the 115 exposed patients (90.4%). Among these patients, 15 (14.4%) became actively infected (n = 8, 7.7%) or colonized (n = 7, 6.7%) with CRE. On univariate analysis, recent antibiotic exposure (66.7% vs 37.1%; P = .046), active inpatient status (60.0% vs 28.1%; P = .034), and a history of cholangiocarcinoma (26.7% vs 3.4%; P = .008) were patient characteristics associated with an increased risk of CRE infection. Biliary stent placement (53.3% vs 22.5%; P = .024) during ERCP was a significant procedure-related risk factor. After adjusting for cholangiocarcinoma, biliary stent placement (odds ratio 3.62; 95% confidence interval, 1.12-11.67), and active inpatient status (odds ratio 3.74; 95% confidence interval, 1.15-12.12) remained independent risk factors for CRE transmission. CONCLUSIONS: In patients undergoing ERCP with a contaminated duodenoscope, biliary stent placement, a diagnosis of cholangiocarcinoma, and active inpatient status are associated with an increased risk of CRE transmission.
Authors: Gheorghe G Balan; Catalin Victor Sfarti; Stefan Andrei Chiriac; Carol Stanciu; Anca Trifan Journal: Eur J Clin Microbiol Infect Dis Date: 2019-09-03 Impact factor: 3.267
Authors: Zachary L Smith; Arshish Dua; Kia Saeian; Nathan A Ledeboer; Mary Beth Graham; Murad Aburajab; Darren D Ballard; Abdul H Khan; Kulwinder S Dua Journal: Dig Dis Sci Date: 2017-07-05 Impact factor: 3.199
Authors: Diederik Persyn; Hannah Van Malenstein; Emma Vanderschueren; Annette Schuermans; Mira Dreesen; Wouter Meert; Kristof Buysschaert; Schalk Van Der Merwe; Wim Laleman Journal: Ann Gastroenterol Date: 2022-06-02
Authors: Rahul Pannala; Bruce Baldwin; Vijay Aluru; Thomas E Grys; Jordan Holmes; Laurence J Miller; M Edwyn Harrison; Cuong C Nguyen; Fred C Tenover; David Persing; Douglas O Faigel Journal: Endosc Int Open Date: 2018-01-12